The Toxidromes: Reading the Poison From the Bedside

What a toxidrome actually is

A toxidrome is a fingerprint — a repeatable constellation of physical signs that points to a class of poison. The word fuses "toxic" and "syndrome": a syndrome caused by a toxin. What makes it useful is that it draws on findings you can gather in ninety seconds at the bedside, no laboratory required. Five channels carry almost all of the information. Vital signs — heart rate, blood pressure, temperature, respiratory rate. Pupils — constricted (miosis) or dilated (mydriasis). Skin — sweaty or bone-dry, flushed or pale. Mental state — agitated and hallucinating, or sedated and unrousable. And bowel sounds — hyperactive or silent. Line those five up and each major class of poison prints a different, recognizable pattern across them. The point is speed: toxicology levels can take hours, and a critically poisoned patient does not have hours. The toxidrome lets you treat the pattern now and confirm the drug later. This is the reflex the Approach to the poisoned patient chapter drills — resuscitate, examine, and classify before you identify.

The cholinergic toxidrome: too much acetylcholine

Block the enzyme that clears acetylcholine and the neurotransmitter floods every synapse it reaches. The organophosphate insecticides and nerve agents inhibit acetylcholinesterase (AChE), the enzyme that switches off acetylcholine. With the off-switch broken, acetylcholine piles up at every cholinergic receptor at once — and the picture splits along the two receptor families the Autonomic nervous system chapter separates. The muscarinic side dominates the classic toxidrome and gives the wettest, most miserable presentation in medicine, captured by two mnemonics. SLUDGE: Salivation, Lacrimation, Urination, Defecation, Gastrointestinal cramping, Emesis. Or DUMBELS: Defecation, Urination, Miosis, Bradycardia/Bronchorrhoea/Bronchospasm, Emesis, Lacrimation, Salivation. Pupils are pinpoint, the heart runs slow, and the airway drowns in secretions — bronchorrhoea, not bronchospasm, is what kills. Layered on top is the nicotinic overlap: acetylcholine also floods the neuromuscular junction and sympathetic ganglia, so the same patient can show muscle fasciculations, weakness, tachycardia and hypertension — a confusing counter-signal to the muscarinic bradycardia.

Management follows the mechanism precisely, and it is a two-drug logic worth understanding rather than memorizing. Atropine is the workhorse: it is a competitive muscarinic antagonist, so it does nothing to the underlying enzyme but blocks the receptors the excess acetylcholine is hammering — drying the secretions and lifting the heart rate. The clinical endpoint is not pupil size but the chest: you titrate atropine up, sometimes to enormous cumulative doses, until the lungs dry out and the patient can breathe. Atropine, however, is blind to the nicotinic problem — it cannot touch the muscle weakness or the paralysis. That is the job of the second drug, pralidoxime, an oxime that reactivates acetylcholinesterase itself by prising the organophosphate off the enzyme. But it works only within a window: over hours the organophosphate–enzyme bond "ages" into a permanent, irreversible state, and once aged, the enzyme cannot be rescued — which is why pralidoxime must be given early. The Organophosphate poisoning chapter carries the full dosing and the ageing timeline.

The anticholinergic toxidrome: the mirror image

Now flip the cholinergic picture on its head. Where the cholinergic patient is wet, the anticholinergic patient is bone-dry, because these poisons block the muscarinic receptor instead of flooding it. The bedside caricature has survived generations of students because every phrase maps to a sign: "mad as a hatter" (agitated delirium, hallucinations, mumbling), "red as a beet" (flushed skin from cutaneous vasodilation), "hot as a hare" (hyperthermia — sweating is switched off, so heat can't escape), "dry as a bone" (dry skin and mucous membranes), "blind as a bat" (dilated pupils, mydriasis, with blurred near vision), and "full as a flask" (urinary retention and an ileus — silent bowel sounds). The heart runs fast. The usual offenders are antihistamines (diphenhydramine), tricyclic antidepressants (TCAs), atropine itself, antipsychotics, and plants — deadly nightshade and datura (jimsonweed). The Anticholinergic poisoning chapter is the deep dive, including the special danger of TCAs, whose sodium-channel blockade makes them far more than a simple anticholinergic.

Sympathomimetic vs anticholinergic: the sweat that decides

Two toxidromes look almost identical across the top — and one sign tells them apart. The sympathomimetic toxidrome is the body in overdrive: cocaine, amphetamines, methamphetamine and cathinones flood the synapse with catecholamines. The result is dilated pupils (mydriasis), tachycardia, hypertension, hyperthermia and agitation — and, crucially, drenching diaphoresis. Line that up against the anticholinergic patient and the overlap is uncanny: both are wide-eyed, fast, hot, hypertensive and delirious. The single most reliable discriminator is the skin. The sympathomimetic patient is soaked in sweat; the anticholinergic patient is bone-dry, because blocking muscarinic receptors shuts off the sweat glands. "Wet versus dry" separates two poisons that otherwise mimic each other point for point. A second clue lives in the gut: sympathomimetics leave bowel sounds normal or brisk, whereas the anticholinergic ileus makes them fall silent. This same sweaty-versus-dry logic underlies why a non-selective beta-blocker is dangerous in cocaine toxicity — a trap the Stimulant toxicity chapter unpacks in full.

The 'down' toxidromes: opioid and sedative-hypnotic

Where the last two toxidromes rev the body up, the next two shut it down — and the discriminator between them is breathing. The opioid toxidrome is a classic triad: pinpoint pupils (miosis), depressed consciousness, and — the sign that kills — respiratory depression, a slow, shallow, ineffective breath. Heroin, fentanyl, methadone and oxycodone all print it. The antidote, naloxone, is a competitive opioid-receptor antagonist that displaces the opioid in seconds; but it is short-acting, so a patient revived from a long-acting opioid such as methadone can slip back into respiratory depression as it wears off and may need repeated doses or an infusion. The Opioid toxicity chapter covers the re-sedation trap and the withdrawal it can precipitate. The sedative-hypnotic toxidrome — benzodiazepines, alcohol, barbiturates, "Z-drugs" — also brings CNS depression and drowsiness, but with a telling difference: the vital signs, and especially the respiratory drive, are relatively preserved in an isolated benzodiazepine overdose. Pupils are usually mid-sized rather than pinpoint. That preserved breathing is the clue that steers you away from opioids — and it is exactly why the reflexive antidote is a trap, as the mistakes below spell out.

The serotonergic toxidrome: the one you feel in the legs

The last of the classic six is serotonin syndrome, and its signature lives in the neuromuscular exam. Too much serotonergic activity — usually from combining serotonergic drugs (an SSRI plus an MAO inhibitor, tramadol, linezolid, or triptans) — produces a triad of altered mental state (agitation, anxiety), autonomic instability (tachycardia, hypertension, hyperthermia, diaphoresis), and, most distinctively, neuromuscular excitation: clonus, hyperreflexia, tremor and rigidity. The tell is that the hyperreflexia and clonus are typically greater in the lower limbs — a finding you can elicit in seconds at the bedside, and one that helps separate serotonin syndrome from its great mimic, the anticholinergic toxidrome (which has normal or reduced reflexes and dry skin, not clonus and sweat). Onset is usually rapid, within hours of a new serotonergic drug or a dose increase. Management is supportive — stop the offending agents, cool aggressively, and control agitation with benzodiazepines; the serotonin antagonist cyproheptadine is reserved for cases that don't settle. The Serotonin syndrome chapter carries the diagnostic Hunter criteria and the full drug-interaction list.